Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024427 |
---|---|
Receipt number | R000028110 |
Scientific Title | Comparison of dapagliflozin, sitagliptin, and metformin as initial drug therapy in patients with type 2 diabetes |
Date of disclosure of the study information | 2016/10/16 |
Last modified on | 2022/10/29 06:15:52 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/10/16 11:04:53 | ||
2 | Update | 2020/04/20 21:16:34 | Date of IRB Last follow-up date |
|
3 | Update | 2020/05/11 14:25:04 | Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2020/06/07 15:29:54 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2021/03/22 20:39:04 | Recruitment status |
|
6 | Update | 2021/07/09 17:24:55 | Date of IRB Anticipated trial start date Last follow-up date |
|
7 | Update | 2022/10/29 06:14:02 | Recruitment status |
|
8 | Update | 2022/10/29 06:15:52 | Publication of results Number of participants that the trial has enrolled |